MELOXICAM for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 70 adverse event reports in the FDA FAERS database where MELOXICAM was used for Psoriasis.
Most Reported Side Effects for MELOXICAM
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 1,815 | 21.0% | 49 | 287 |
| Arthralgia | 819 | 9.5% | 127 | 192 |
| Drug hypersensitivity | 776 | 9.0% | 105 | 130 |
| Pain | 709 | 8.2% | 99 | 176 |
| Pain in extremity | 603 | 7.0% | 70 | 116 |
| Joint swelling | 566 | 6.5% | 105 | 136 |
| Peripheral swelling | 557 | 6.4% | 101 | 131 |
| Dizziness | 542 | 6.3% | 107 | 185 |
| Fatigue | 532 | 6.1% | 112 | 179 |
| Nausea | 527 | 6.1% | 94 | 189 |
| Musculoskeletal stiffness | 493 | 5.7% | 105 | 122 |
| Dyspnoea | 474 | 5.5% | 118 | 275 |
| Diarrhoea | 471 | 5.4% | 99 | 156 |
| Rheumatoid arthritis | 468 | 5.4% | 112 | 145 |
| Malaise | 437 | 5.1% | 99 | 135 |
Other Indications for MELOXICAM
Product used for unknown indication (3,954)
Pain (539)
Rheumatoid arthritis (508)
Arthritis (379)
Arthralgia (293)
Osteoarthritis (280)
Back pain (222)
Inflammation (132)
Psoriatic arthropathy (114)
Ankylosing spondylitis (67)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)